Clinical Research, Pharma & Healthcare FinancingOrbis Medicines Appoints Mikael Dolsten as Board ChairBusiness WireMarch 5, 2025March 6, 2025 by Business WireMarch 5, 2025March 6, 2025050 Orbis Medicines, a leader in oral macrocycle drug discovery, today announces the appointment of Mikael Dolsten, M.D., Ph.D., former Chief Scientific Officer, President, Pfizer Research...